KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Abbott Laboratories (ABT) Profit After Tax (2016 - 2025)

Abbott Laboratories (ABT) has disclosed Profit After Tax for 17 consecutive years, with $1.8 billion as the latest value for Q4 2025.

  • Quarterly Profit After Tax fell 80.76% to $1.8 billion in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $6.5 billion through Dec 2025, down 51.32% year-over-year, with the annual reading at $6.5 billion for FY2025, 51.32% down from the prior year.
  • Profit After Tax hit $1.8 billion in Q4 2025 for Abbott Laboratories, up from $1.6 billion in the prior quarter.
  • In the past five years, Profit After Tax ranged from a high of $9.2 billion in Q4 2024 to a low of $1.0 billion in Q4 2022.
  • Historically, Profit After Tax has averaged $2.0 billion across 5 years, with a median of $1.6 billion in 2023.
  • Biggest five-year swings in Profit After Tax: soared 478.98% in 2024 and later crashed 80.76% in 2025.
  • Year by year, Profit After Tax stood at $2.0 billion in 2021, then crashed by 48.06% to $1.0 billion in 2022, then soared by 54.31% to $1.6 billion in 2023, then skyrocketed by 478.98% to $9.2 billion in 2024, then plummeted by 80.76% to $1.8 billion in 2025.
  • Business Quant data shows Profit After Tax for ABT at $1.8 billion in Q4 2025, $1.6 billion in Q3 2025, and $1.8 billion in Q2 2025.